|Day Low/High||4.70 / 4.80|
|52 Wk Low/High||2.93 / 4.62|
Enzyme developed with CodeEvolver® technology for preclinical therapeutics program exceeds agreement requirements
Codexis, Inc. (Nasdaq: CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces the filing of a lawsuit against EnzymeWorks and its founder, Junhua "Alex" Tao, for willful...
Stocks with insider trader activity include CDXS, KN and CNBKA